Raptiva Dangerous Drug Lawsuit to be Heard

Share This:
 

The first of nearly 100 consolidated dangerous drug lawsuits against the Roche Holding AG’s Genentech Inc. psoriasis medication Raptiva will be heard this month in California state court.

According to the dangerous drug lawsuit, 46-year-old Louisiana resident Stephen Johnson was healthy when he began taking Raptiva to treat his psoriasis. However, Johnson’s immune system was weakened by the medication and he eventually developed a brain infection that led to his death.

Doctors at the emergency room he was transported to determined that Johnson’s death was probably caused by “overwhelming sepsis complicated by the fact that patient was relatively immunosuppressed from his Raptiva” the lawsuit stated, according to Business Week.

Johnson’s case will be the first of approximately 100 dangerous drug lawsuits involving Raptiva that have been consolidated before Judge Steven Brick in state court in Oakland, California. Johnson’s family is seeking $15 million in compensatory damages, as well as “several hundred million dollars” in punitive damages, according to the lawsuit.

Raptiva was approved for sale by the U.S. Food and Drug Administration in 2003, and was being used by approximately 2,000 patients in 2009 when it was recalled amid fears that it increased the risk of brain infections.

If you or a loved one have been harmed by a dangerous drug such as Raptiva, call Sokolove Law today to learn more about potentially pursuing a dangerous drug lawsuit.